On the occasion of the 78th Independence Day, Sudarshan Jain, Secretary General of the Indian Pharmaceutical Alliance (IPA), shared his insights with ETHealthworld's Prathiba Raju on the pivotal role of India's pharmaceutical industry in the nation's future and its potential to become a global healthcare leader. Valued at $58 billion with $19.5 billion in foreign exchange earnings, Jain envisions the industry reaching $120 billion by 2030 and $400 to $450 billion by 2047, with foreign exchange earnings soaring to $200 billion.
